Stock Market & Financial Investment News

News Breaks October 2, 2012 07:02 EDT ATRS, PFE Antares Pharma receives development milestone payment Antares Pharma (ATRS) announced that its partner Pfizer (PFE) achieved a development milestone related to its undisclosed Consumer Healthcare product. This development milestone in Antares’ collaboration with Pfizer triggers a $750,000 payment to Antares. In December of 2011, Antares licensed to Pfizer’s Consumer Healthcare Business Unit one of its drug delivery technologies to develop an undisclosed product on an exclusive basis for North America. Pfizer has assumed full cost and responsibility for all clinical development, manufacturing and commercialization of the product in the licensed territory, which also includes certain non-exclusive territories outside of North America. Antares received an upfront payment, and will receive development and sales based milestones, as well as royalties on net sales for three years post launch in the U.S. News For ATRS;PFE From The Last 14 Days Check below for free stories on ATRS;PFE the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 18, 2013 09:38 EDT PFE Active equity option families trading on open Active equity option families trading on open according to Track Data: AAPL NFLX GOOG PFE TSLA MGM June 17, 2013 16:00 EDT PFE Options Update; June 17, 2013 Subscribe for More Information 08:36 EDT PFE InSite Vision to join Merck, Pfizer patent suit against Mylan InSite Vision (INSV) announced that it will join Merck (MRK) and Pfizer (PFE) in filing a patent infringement lawsuit against Mylan Pharmaceuticals (MYL). Mylan recently filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking to market a generic version of AzaSite before expiration of the patents covering AzaSite and its use. AzaSite is marketed by Merck in the U.S. On May 26, 2011, InSite and Merck filed a similar patent infringement lawsuit against Sandoz. A trial date for the Sandoz ANDA suit has been set for July 11, 2013. The companies have agreed that Merck will take the lead in prosecuting both lawsuits. Each company will be responsible for their own legal costs, with InSite assuming a monitoring role, the company said. 07:28 EDT PFE Cambridge Healthtech Institute to host a conference Subscribe for More Information June 14, 2013 16:00 EDT PFE Options Update; June 14, 2013 Subscribe for More Information 06:45 EDT PFE Zoetis volatility elevated into Pfizer split-off Subscribe for More Information June 13, 2013 16:00 EDT PFE Options Update; June 13, 2013 Subscribe for More Information 07:32 EDT PFE European League Against Rheumatism to host annual meeting Subscribe for More Information 07:05 EDT ATRS Antares Pharma's auto-injection device shows positive results in clinical study Antares Pharma announced clinical study results demonstrating that subcutaneous methotrexate delivered with a new, self-administration device demonstrates bioavailability that is significantly greater than oral methotrexate in the treatment of adults with rheumatoid arthritis. The self-administration device is one component of an investigational product under review by the FDA that combines the company's proprietary Vibex auto-injection delivery device with an injectable version of methotrexate, the drug long regarded as the standard of care in the treatment of rheumatoid arthritis. June 12, 2013 16:02 EDT PFE Options Update; June 12, 2013 Subscribe for More Information 13:31 EDT PFE Mylan could be interested in generic assets split from Pfizer, Bloomberg says 08:28 EDT PFE Teva to pay $1.6B to settle with Pfizer, Nycomed over generic Protonix Subscribe for More Information 08:02 EDT PFE Pfizer wins $2.15B settlement from Teva and Sun for patent infringement Subscribe for More Information June 11, 2013 16:00 EDT PFE Options Update; June 11, 2013 Subscribe for More Information 15:15 EDT PFE Pfizer June volatility at one-year high Subscribe for More Information 07:42 EDT PFE Boston Biotech Conferences to host a conference Subscribe for More Information June 10, 2013 07:40 EDT PFE Leerink's biotech analyst holds analyst/industry conference call on ASCO Subscribe for More Information 07:20 EDT PFE Biomed to host a conference Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.